/
We are a medical technology company focused on (i) diagnostic, ablation and deep brain stimulation technology for brain related conditions such as epilepsy and Parkinson s disease; (ii) ablation and stimulation for pain management throughout the body; and (iii) drug delivery including diagnostic and stimulation capabilities. We have received 510(k) clearance for four of our devices from the Foo…
The business is unprofitable at the operating level (-46.46% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue up 163.5% YoY with margins expanding 297.8pp.
Negative free cash flow of -$3M. The business is consuming cash, not generating it.
Profitability & Returns
Revenue (TTM)
$10M
▲ +163.5% YoY
Net Income (TTM)
-$7M
▲ +70.7% YoY
Op. Margin
-72.69%
▲ +297.8pp YoY
ROIC
-79.65%
▲ +168.8pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$8M
▲ +73.8% YoY
Op. Cash Flow (TTM)
-$7M
▲ +74.2% YoY
Net Debt
-$3M
Net Cash Position
Cash & Equiv.
$3M
Continue Research